ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial Post author:Sam Post published:December 7, 2017 Post category:BioPharma Resources redirected to progress new drug candidates to clinic in H1 2018. Source: BioSpace You Might Also Like <b>Sonoma Pharma</b> Release: Company Announces Fiscal Third Quarter 2017 Financial Results And Conference Call January 25, 2017 Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO November 13, 2017 Pieris Surged on $82.75 Million Anemia Drug Deal February 27, 2017
<b>Sonoma Pharma</b> Release: Company Announces Fiscal Third Quarter 2017 Financial Results And Conference Call January 25, 2017
